Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Advances in metastatic non small cell lung cancer

Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Advances in metastatic non small cell lung cancer ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
21 Oct 2018

Use of T-VEC in early metastatic melanoma

Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands
Use of T-VEC in early metastatic melanoma ( Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018

KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC

Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC ( Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA )
21 Oct 2018

PEACE: Collecting cancer tissue to solve the riddle of metastasis

Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK
PEACE: Collecting cancer tissue to solve the riddle of metastasis ( Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK )
21 Oct 2018

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma

Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma ( Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )
21 Oct 2018

JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma

Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA
JAVELIN Renal 101 trial: avelumab and axitinib for advanced renal cell carcinoma ( Dr Robert J. Motzer - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Oct 2018

The past, present and future of treating ovarian cancer

Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The past, present and future of treating ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
21 Oct 2018

Comment on SOLO-1 for advanced ovarian cancer

Dr Jonathan Ledermann - University College London, London, UK
Comment on SOLO-1 for advanced ovarian cancer ( Dr Jonathan Ledermann - University College London, London, UK )
21 Oct 2018

Olaparib improves progression free survival up front in ovarian cancer

Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
Olaparib improves progression free survival up front in ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
21 Oct 2018

A novel bifunctional fusion protein for combatting lung cancer

Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain
A novel bifunctional fusion protein for combatting lung cancer ( Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain )
21 Oct 2018

Comment on new treatment options for breast cancer

Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany
Comment on new treatment options for breast cancer ( Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany )
20 Oct 2018

Early stage trials in immunotherapy and brain screening

Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Early stage trials in immunotherapy and brain screening ( Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
20 Oct 2018